Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2B | P29275 | 12/20 | 1.00 |
| ▸ | ADORA2A | P29274 | 11/20 | 1.00 |
| ▸ | ADORA3 | P0DMS8 | 7/20 | 1.00 |
| ▸ | ADORA1 | P30542 | 6/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.75 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.75 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.75 |
| ▸ | MAPT | P10636 | 1/20 | 0.75 |
| ▸ | HPGD | P15428 | 1/20 | 0.75 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.75 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.75 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.75 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.75 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7220779 | 0.88 | ADORA2B (1.00) | ADORA2BADORA2AADORA3ADORA1KDM4E | |
| Xanthine Amine Congener SCHEMBL1000686 | 0.86 | ADORA2A (1.00) | ADORA2BADORA2AADORA3ADORA1KDM4E | |
| SCHEMBL7227160 | 0.85 | ADORA2B (1.00) | ADORA2BADORA2AADORA3ADORA1KDM4E | |
| SCHEMBL7235224 | 0.85 | ADORA2B (1.00) | ADORA2BADORA2AADORA3ADORA1 | |
| Xanthine Amine Congener SCHEMBL25227375 | 0.85 | ADORA2A (0.98) | ADORA2BADORA2AADORA3ADORA1KDM4E | |
| Xanthine Amine Congener SCHEMBL15124872 | 0.85 | ADORA2A (0.98) | ADORA2BADORA2AADORA3ADORA1KDM4E | |
| SCHEMBL7228029 | 0.84 | ADORA2B (1.00) | ADORA2BADORA2AADORA3ADORA1 | |
| SCHEMBL1065789 | 0.84 | ADORA2B (0.73) | ADORA2BADORA2AADORA3ADORA1KDM4E | |
| SCHEMBL1223882 | 0.83 | ADORA2B (1.00) | ADORA2BADORA2AADORA3ADORA1KDM4E | |
| SCHEMBL9159693 | 0.82 | ADORA2A (0.77) | ADORA2BADORA2AADORA3ADORA1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6545002-B1 | Treating asthma, diarrhea, insulin resistance, diabetes, ischemia/reprefusion injuries, diabetic retinopathy or hyperbaric oxygen-induced retinopathy | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | 2003-04-08 | — | — | US | disclosed |